Literature DB >> 18346582

Vascular endothelial growth factor induces extracellular matrix proteins and osteopontin in the umbilical artery.

Manfred Infanger1, Jirka Grosse, Kriss Westphal, Annekatrin Leder, Claudia Ulbrich, Martin Paul, Daniela Grimm.   

Abstract

Vascular endothelial growth factor (VEGF) is a mitogenic, angiogenic, and potent mediator of vascular permeability. It plays a role in injuries, contributes to edema during the acute stage of tissue damage, and promotes repair during recovery. We recently showed that VEGF serum levels of burn patients with a considerable number of damaged vessels were significantly increased. Here, we study the effects of VEGF on healthy vessels treated with a comparable VEGF concentration achieved in patients suffering heavy burns. VEGF 165 (0.2 mL of 10 ng/mL) or vehicle (saline 0.9%) was intraluminally applied to umbilical arteries for 90 min at 37 degrees C. Then, the cord was perfused for 4 hr. During perfusion, functional and biochemical parameters were kept within normal physiological ranges. Afterward, the vessels were analyzed applying morphometry, sirius red staining, polarization microscopy, Western blot analysis, and immunohistochemistry. Moreover, cultured human umbilical vein endothelial cells (HUVECs) were treated with VEGF or vehicle for 90 min and 5.5 hr to examine extracellular matrix (ECM) proteins and receptor tyrosine kinases. VEGF-treated umbilical arteries showed significant tissue edema and simultaneously an enhancement of laminin and collagen types I, III, and IV compared with control arteries. We detected an increase in Flt-1, Flk-1, osteopontin, and ss(1)-integrin. VEGF induced laminin early in HUVECs as measured by flow cytometry. In parallel, VEGF induced a higher amount of osteopontin, ss(1)-integrin, and both receptor tyrosine kinases in endothelial cells within 90 min. Intraluminal application of VEGF enhances ECM protein, osteopontin, and ss(1)-integrin production of the endothelium, while it still generates tissue edema. VEGF initiates vascular remodeling as early as it generates edema, even if the target vessel is not damaged. Osteopontin and ss(1)-integrin, both induced by VEGF, may play an important role in the vascular remodeling process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346582     DOI: 10.1016/j.avsg.2007.11.002

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  14 in total

Review 1.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

2.  Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.

Authors:  Jonathan M Dreyfuss; Mark D Johnson; Peter J Park
Journal:  Mol Cancer       Date:  2009-09-04       Impact factor: 27.401

3.  Sdc1 overexpression inhibits the p38 MAPK pathway and lessens fibrotic ventricular remodeling in MI rats.

Authors:  Juan Lei; Shengneng Xue; Wei Wu; Shuxian Zhou; Yuling Zhang; Guiyi Yuan; Jingfeng Wang
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

4.  Dysregulation of inflammatory cytokines and inhibition of VEGFA in the human umbilical cord are associated with negative pregnancy outcomes.

Authors:  Camron Chehroudi; Hugh Kim; Tricia E Wright; Abby C Collier
Journal:  Placenta       Date:  2019-09-03       Impact factor: 3.481

Review 5.  Biomarkers for anti-angiogenic therapy in cancer.

Authors:  Markus Wehland; Johann Bauer; Nils E Magnusson; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 6.  Anti-vascular endothelial growth factor therapy in breast cancer.

Authors:  Tina Bøgelund Kristensen; Malin L T Knutsson; Markus Wehland; Britt Elmedal Laursen; Daniela Grimm; Elisabeth Warnke; Nils E Magnusson
Journal:  Int J Mol Sci       Date:  2014-12-11       Impact factor: 5.923

7.  Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass.

Authors:  Judith Agudo; Eduard Ayuso; Veronica Jimenez; Alba Casellas; Cristina Mallol; Ariana Salavert; Sabrina Tafuro; Mercè Obach; Albert Ruzo; Marta Moya; Anna Pujol; Fatima Bosch
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

8.  Genomic approach to identify factors that drive the formation of three-dimensional structures by EA.hy926 endothelial cells.

Authors:  Xiao Ma; Markus Wehland; Herbert Schulz; Katrin Saar; Norbert Hübner; Manfred Infanger; Johann Bauer; Daniela Grimm
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

9.  Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity.

Authors:  Sascha Kopp; Elisabeth Warnke; Markus Wehland; Ganna Aleshcheva; Nils E Magnusson; Ruth Hemmersbach; Thomas Juhl Corydon; Johann Bauer; Manfred Infanger; Daniela Grimm
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

10.  Buyanghuanwu decoction promotes angiogenesis after cerebral ischemia/reperfusion injury: mechanisms of brain tissue repair.

Authors:  Zhen-Qiang Zhang; Jun-Ying Song; Ya-Quan Jia; Yun-Ke Zhang
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.